In Part I of this three-part series, we focused on three mRNA technology market players: BioNTech, Moderna and CureVac.
Continue Reading The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)
The Supreme Court’s recent landmark ruling in Google v. Oracle ended a decade-long legal battle between the tech giants, finding
Continue Reading Key Takeaways from Google’s Supreme Court Copyright Win Over Oracle
A patent gives the patent holder the right to exclude others from making, using, selling, offering to sell, or importing
Continue Reading When Do My Patents Expire?
Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the
Continue Reading The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I
Bigfoot Biomedical®, a Milpitas, CA emerging company, recently announced that it has secured new financing of up to $57
Continue Reading Bigfoot Biomedical® Secures up to $57 Million in Financing from Madryn Asset Management
Owning a federal trademark registration provides the ability to exclude others from using a certain word or design in association
Continue Reading Intent-to-Use Applications: Pros and Cons
Patent examiners operate under a complex network of production and quality incentives that influence the likelihood that an examiner will
Continue Reading Patent Strategy Should Consider Examiner Incentives
Founders of emerging companies must decide early on in their company’s growth cycle whether to require employees to assign their
Continue Reading IP Assignment Considerations for Emerging Companies
Since the U.S. patent law switched to the first-inventor-to-file system in 2013, provisional applications have become more popular as the
Continue Reading Considerations for Protecting your Invention with Provisional Patent Applications
2021 started off well for Dana-Farber Cancer Institute, with the launch of its new venture fund, Binney Street Capital,
Continue Reading Dana-Farber Launches New Fund to Support Oncology Startups